EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alpha-Lipoic Acid and Saxagliptin Attenuate Ferroptosis-Related Ovarian Injury and Modulate FGF21/NOX4–NRF2/HO-1 Signaling in Letrozole-Induced Polycystic Ovary Syndrome

Eman H Yousef iD, Mona H Zohny iD, Ebtsam S Abdel-Lah, Mostafa E Metawee, Hader I Sakr, Mohamed M Salama iD

International Journal of Molecular Sciences · 30.10.2026 · 27 (21) · 9779

DOI: 10.3390/ijms27219779 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.10.2026. Verfasst von Eman H Yousef und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Biochemistry (Biochemistry), Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, Egypt. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Thioctic Acid, Ferroptosis, Adamantane. Die Arbeit nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is a complex endocrine-metabolic disorder characterized by ovarian dysfunction, hormonal imbalance, and emerging ferroptosis-related abnormalities. This study investigated the effects of alpha-lipoic acid (ALA), saxagliptin (Saxa), and their combination in a letrozole-induced PCOS model, with focus on the ovarian FGF21/NOX4–NRF2/HO-1 and ferroptosis-related pathways. PCOS was induced in female rats by oral letrozole administration for 21 days. Rats were allocated into control, PCOS, ALA, Saxa, and ALA/Saxa groups, followed by 14 days of treatment. Body weight, ovarian index, ovarian histopathology, reproductive hormones, oxidative stress markers, ovarian FGF21 and NOX4 expression, NRF2/HO-1 signaling, and ferroptosis-related markers, including Fe2+, GPX4, and SLC7A11, were assessed. Letrozole induced weight gain, ovarian hypertrophy, follicular disruption, endocrine imbalance, and ferroptosis-related alterations, marked by increased ROS, MDA, Fe2+, and NOX4, alongside reduced FGF21, NRF2/HO-1, GPX4, and SLC7A11. ALA or Saxa attenuated these alterations, whereas ALA/Saxa produced greater improvements in ovarian morphology, hormonal status, redox homeostasis, and ferroptosis-related markers. These effects were associated with FGF21 upregulation, NOX4 suppression, enhanced NRF2/HO-1 signaling, and preservation of GPX4 and SLC7A11. In conclusion, ALA/Saxa therapy markedly ameliorated letrozole-induced PCOS in rats, accompanied by restoration of ovarian FGF21/NOX4 homeostasis, associated with enhancement of NRF2/HO-1 antioxidant responses, and attenuation of ferroptosis-related alterations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeThioctic AcidFerroptosisAdamantaneOvaryDipeptidesAnimalsFemaleLetrozoleNF-E2-Related Factor 2NADPH Oxidase 4Fibroblast Growth FactorsRatsSignal TransductionOxidative StressRats, Sprague-DawleyHeme Oxygenase (Decyclizing)

Stichwörter der Autor:innen

FGF21NOX4NRF2alpha-lipoic acidferroptosispolycystic ovary syndromesaxagliptin

Substanzen

LetrozoleNF-E2-Related Factor 2NADPH Oxidase 4Fibroblast Growth FactorsThioctic AcidNox4 protein, ratAdamantanefibroblast growth factor 21Dipeptidessaxagliptin

Autor:innen und Institutionen

  • Department of Pharmacology and Biochemistry (Biochemistry), Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, Egypt.
  • Department of Pharmacology and Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa 11152, Egypt.
  • Department of Pharmacology, Faculty of Veterinary Medicine, Assiut University, Assiut 71526, Egypt.
  • Department of Pharmacology, School of Veterinary Medicine, Badr University in Assiut (BUA), Naser City 11829, Egypt.
  • Department of Histology, Faculty of Medicine (Boys), Al-Azhar University, Cairo 11884, Egypt.
  • Department of Histology, General Medicine Practice Program, Batterjee Medical College, Jeddah 21442, Saudi Arabia.

ORCID-Profile: Eman H Yousef, Mona H Zohny, Mohamed M Salama

Zitieren

APA

Yousef, E. H., Zohny, M. H., Abdel-Lah, E. S., Metawee, M. E., Sakr, H. I., & Salama, M. M. (2026). Alpha-Lipoic Acid and Saxagliptin Attenuate Ferroptosis-Related Ovarian Injury and Modulate FGF21/NOX4–NRF2/HO-1 Signaling in Letrozole-Induced Polycystic Ovary Syndrome. International Journal of Molecular Sciences, 27(21), 9779. https://doi.org/10.3390/ijms27219779

Vancouver

Yousef EH, Zohny MH, Abdel-Lah ES, Metawee ME, Sakr HI, Salama MM. Alpha-Lipoic Acid and Saxagliptin Attenuate Ferroptosis-Related Ovarian Injury and Modulate FGF21/NOX4–NRF2/HO-1 Signaling in Letrozole-Induced Polycystic Ovary Syndrome. International Journal of Molecular Sciences. 2026;27(21):9779. doi:10.3390/ijms27219779

BibTeX
@article{Yousef2026,
  author = {Yousef, Eman H and Zohny, Mona H and Abdel-Lah, Ebtsam S and Metawee, Mostafa E and Sakr, Hader I and Salama, Mohamed M},
  title = {Alpha-Lipoic Acid and Saxagliptin Attenuate Ferroptosis-Related Ovarian Injury and Modulate FGF21/NOX4–NRF2/HO-1 Signaling in Letrozole-Induced Polycystic Ovary Syndrome},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9779},
  doi = {10.3390/ijms27219779}
}
Kostenlos starten →